Skip to main content

Why choose Hizentra for PI therapy?

Infusion schedule icon PI

Choose when and where you infuse


Self-administration with Hizentra means you and your doctor can decide when and where you can infuse. Flexible dosing options (from daily to once every 2 weeks) mean you won't have to adjust or cancel your plans due to IV infusion appointments.

Travel may be easier with Hizentra Prefilled Syringes too.

pre filled syringe icon

No more IV infusions


IV infusions can be challenging for people who have hard-to-find or damaged veins. Hizentra allows you to infuse just under the skin, not into a vein, after training from your doctor.

Safety icon PI

Proven safety


Hizentra has an established safety profile and demonstrated tolerability. In clinical trials, the most common side effects were redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible.

Real patient experience in PI

Real patient experience in PI

Annette

  • Wife and mother of 6 children
  • Daughter's PI diagnosis led to her own 8 years later
  • Enjoying the convenience of Hizentra prefilled syringes
Watch Video

Hizentra helps you maintain consistent Ig levels, which can make a difference in how you feel

person and lines going up and down

With IVIg dosing every 3–4 weeks, you may experience highs and lows between infusions.

person and lines going up and down with less dramatic peaks and valleys

Hizentra flexible dosing provides smaller, more frequent doses than IVIg. More steady Ig levels may reduce potential for side effects between infusions.

Join a free educational online program for people with PI and their caregivers

Hizentra Live Webinar

Hizentra Live Webinar Series features:

  • Presentations from a trained nurse
  • Stories from people like you living with PI
  • Q&A sessions where you can participate
Register for a live webinar 
acuity
You are now leaving the current website.

Do you want to continue?

No Yes